Validity of a reported history of chickenpox in targeting varicella vaccination at susceptible adolescents in England

Vaccine

Volumn 32, Issue 10, 2014, Pages 1213-1217

  Field, Nigel ^a,b   Amirthalingam, Gayatri ^a   Waight, Pauline ^a   Andrews, Nick ^a   Ladhani, Shamez N ^a   van Hoek, Albert Jan ^a   Maple, Peter A C ^a   Brown, Kevin E ^a   Miller, Elizabeth ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Adolescent; Chickenpox; Reported history; Vaccination programme; Validity; Varicella

Indexed keywords

ADOLESCENT; CHICKENPOX; REPORTED HISTORY; VACCINATION PROGRAMME; VALIDITY; VARICELLA;

ADOLESCENT; ANTIBODIES, VIRAL; CHICKENPOX; CHICKENPOX VACCINE; CHILD; COST-BENEFIT ANALYSIS; ENGLAND; HUMANS; IMMUNIZATION PROGRAMS; IMMUNOGLOBULIN G; MEDICAL HISTORY TAKING; PREDICTIVE VALUE OF TESTS;

EID: 84893916959     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.06.098     Document Type: Article

References (34)

1. Heininger U., Seward J.F., Varicella Lancet 2006, 368:1365-1376.
2. Vyse A.J., Gay N.J., Hesketh L.M., Morgan-Capner P., Miller E. Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults. Epidemiol Infect 2004, 132:1129-1134.
3. Halloran M.E., Cochi S.L., Lieu T.A., Wharton M., Fehrs L. Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. Am J Epidemiol 1994, 140:81-104.
4. Schuette M.C., Hethcote H.W. Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles. Bull Math Biol 1999, 61:1031-1064.
5. Brisson M., Edmunds W.J., Gay N.J., Law B., De Serres G. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect 2000, 125:651-669.
6. Joint Committee on Vaccination and Immunisation (JCVI) Statement on Varicella and Herpes Zoster vaccines 2010, at http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@ab/documents/digitalasset/dh_114908.pdf.
7. Joint Committee on Vaccination and Immunisation (JCVI) sub-committee on adolescent vaccinations Minutes of meeting held on 27 January 2012 2012, at https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/158008/JCVI-Minutes-of-sub-committee-on-adolescent-vaccinations-27-January-2012.pdf.
8. Nigatu W., Samuel D., Cohen B., Cumberland P., Lemma E., Brown D.W. Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys. Vaccine 2008, 26:4769-4774.
9. Office for National Statistics (ONS) Population estimates by ethnic group (experimental), mid-2009: published ad hoc data and analysis: Population June 2012: Reference number 000041 2011, at http://www.ons.gov.uk/ons/about-ons/what-we-do/publication-scheme/published-ad-hoc-data/population/june-2012/index.html.
10. Talukder Y.S., Kafatos G., Pinot de Moira A., Aquilina J., Parker S.P., Crowcroft N.S. The seroepidemiology of varicella zoster virus among pregnant Bangladeshi and white British women in the London Borough of Tower Hamlets, UK. Epidemiol Infect 2007, 135:1344-1353.
11. MacMahon E., Brown L.J., Bexley S., Snashall D.C., Patel D. Identification of potential candidates for varicella vaccination by history: questionnaire and seroprevalence study. BMJ 2004, 329:551-552.
12. Maple P.A.C., Gray J., Brown K.E., Brown D. Performance characteristics of a quantitative, standardised varicella zoster IgG time resolved fluorescence immunoassay (VZV TRFIA) for measuring antibody following natural infection. J Virol Methods 2009, 157:90-92.
13. Manikkavasagan G.M., Bedford H., Peckham C.S., Dezateux C. Antenatal Screening for Susceptibility to Varicella Zoster Virus (VZV) in the United Kingdom 2009, at http://www.screening.nhs.uk/varicella.
14. Immunise - National Immunisation Program Schedule, at. http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/nips-ctn.
15. Vaccination schedules, at. http://ecdc.europa.eu/en/activities/surveillance/euvac/schedules/Pages/schedules.aspx.
16. Katsafadou A., Kallergi K., Ferentinos G., Goulioti T., Foustoukou M., Papaevangelou V. Presumptive varicella vaccination is warranted in Greek adolescents lacking a history of disease or household exposure. Eur J Pediatr 2009, 168:23-25.
17. Heininger U., Baer G., Bonhoeffer J., Schaad U.B. Reliability of varicella history in children and adolescents. Swiss Med Wkly 2005, 135:252-255.
18. Koturoglu G., Kurugol Z., Turkoglu E. Seroepidemiology of varicella-zoster virus and reliability of varicella history in Turkish children, adolescents and adults. Paediatr Perinatal Epidemiol 2011, 25:388-393.
19. Ronan K., Wallace M.R. The utility of serologic testing for varicella in an adolescent population. Vaccine 2001, 19:4700-4702.
20. De Juanes J.R., Gil A., San-Martín M., González A., Esteban J., García de Codes A. Seroprevalence of varicella antibodies in healthcare workers and health sciences students. Reliability of self-reported history of varicella. Vaccine 2005, 23:1434-1436.
21. Almuneef M., Memish Z.A., Abbas M.E., Balkhy H.H. Screening healthcare workers for varicella-zoster virus: can we trust the history?. Infect Control Hosp Epidemiol 2004, 25:595-598.
22. Nordin J., Baken L., Carlson R., Hering J. Age-specific rates of serological immunity in patients with a negative history for varicella infection. Infect Control Hosp Epidemiol 1998, 19:823-824.
23. Diez-Domingo J., Gil A., San-Martín M., González A., Esteban J., Baldó J.M. Seroprevalence of varicella among children and adolescents in Valencia, Spain. Reliability of the parent's reported history and the medical file for identification of potential candidates for vaccination. Hum Vaccin 2005, 1:204-206.
24. Watson B., Civen R., Reynolds M., Heath K., Perella D., Carbajal T. Validity of self-reported varicella disease history in pregnant women attending prenatal clinics. Public Health Rep 2007, 122:499-506.
25. Karunajeewa H.A., Kelly H.A. Predictive value of personal recall of chicken pox infection: implications for the use of varicella vaccine. Med J Aust 2001, 174:153.
26. Silverman N.S., Ewing S.H., Todi N., Montgomery O.C. Maternal varicella history as a predictor of varicella immune status. J Perinatol 1996, 16:35-38.
27. Christiansen D., Barnett E.D. Comparison of varicella history with presence of varicella antibody in refugees. Vaccine 2004, 22:4233-4237.
28. Arteaga A., Desviat P.V., Jaqueti J., Santos J., de Miguel A.G., Garcia R.J. Self-reported history of vaccination and disease and immunity against hepatitis A, hepatitis B, tetanus, diphtheria and varicella among spanish military recruits. Hum Vaccin 2010, 6:198-201.
29. Dashraath P., Ong E.S., Lee V.J. Seroepidemiology of varicella and the reliability of a self-reported history of varicella infection in Singapore military recruits. Ann Acad Med Singap 2007, 36:636-641.
30. Linder N., Ferber A., Kopilov U., Smetana Z., Barzilai A., Mendelson E. Reported exposure to chickenpox: a predictor of positive anti-varicella-zoster antibodies in parturient women. Fetal Diagn Ther 2001, 16:423-426.
31. Kavaliotis J., Petridou S., Karabaxoglou D. How reliable is the history of chickenpox? Varicella serology among children up to 14 years of age. Int J Infect Dis 2003, 7:274-277.
32. Thiry N., Beutels P., Van Damme P., Van Doorslaer E. Economic evaluations of varicella vaccination programmes: a review of the literature. Pharmacoeconomics 2003, 21:13-38.
33. Rozenbaum M.H., van Hoek A.J., Vegter S., Postma M.J. Cost-effectiveness of varicella vaccination programs: an update of the literature. Expert Rev Vaccines 2008, 7:753-782.
34. Joint Committee on Vaccination and Immunisation (JCVI) statement on the use of meningococcal C vaccines in the routine childhood immunisation programme 2012, at http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@ab/documents/digitalasset/dh_132443.pdf.